MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Safety of opicapone after 5 years of post-marketing experience worldwide

    L. Guedes, J. Graça, M. Sampaio, M. Vieira, F. Rocha, H. Gama (Coronado, Portugal)

    Objective: To review the safety data of opicapone (OPC) after five years of marketing experience worldwide Background: OPC is a once-daily catechol-O-methyltransferase (COMT) inhibitor proven…
  • 2022 International Congress

    The REONPARK (REgistry of the use of COMT-inhibitors in the maNagement of patients with PARKinson’s disease in Spain who present early motor fluctuations) study: rationale and design of a national, multicentre and prospective study

    L. Lopez-Manzanares, E. Casas-Peña, I. Muro-Garcia, I. Caballero, F. Almeida, I. Tegel, P. Sarasa (Madrid, Spain)

    Objective: To describe the real-world use of catechol-O-methyltransferase (COMT) inhibitors add on to levodopa/dopa decarboxylase inhibitor (DDCI) in patients with Parkinson’s disease (PD) suffering from…
  • 2022 International Congress

    Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease

    T. Kosuri, J. Brasic (Baltimore, USA)

    Objective: We sought to develop a protocol to utilize continuous wavelet transforms (CWTs) to rate the severity of movements to obtain optimal classifications of PD.…
  • 2022 International Congress

    An Ecologic Study of Aqueous Lead Exposure and Parkinson’s Disease

    G. Schwartz, M. Williamson (Grand Forks, USA)

    Objective: Examine the potential role of lead in water as a risk factor for PD. Background: Studying disease rates in different locations is an established…
  • 2022 International Congress

    Multidimensional phenotyping of human stem cell-derived midbrain dopaminergic neurons from a SNCA triplication carrier for drug screening applications

    J. Wilbertz, V. Gorgogietas, L. Cousin, A. Vuidel, I. Boussaad, R. Krüger, P. Sommer (Strasbourg, France)

    Objective: We hypothesized that combining multiple Parkinson's disease (PD) relevant cellular phenotypes will increase the accuracy, stability, and usability of human midbrain dopaminergic (mDA) neuronal…
  • 2022 International Congress

    Subclinical cognitive patterns of caudate-anchored connectivity in early Parkinson’s disease

    S-W. Yoo, J-S. Kim, K-S. Lee (Seoul, Republic of Korea)

    Objective: This study is aimed at elucidating the changes of cognitive connectivity according to orthostatic stress in early Parkinson’s disease (PD). Background: 18F-Florbetaben tracer can…
  • 2022 International Congress

    Resequencing of the complete SNCA locus in Indian patients with Parkinson’s disease

    A. Kishore, M. Sturm, S. Krishnan, G. Sarma, C. Hakkaart, A. Sreelatha (Kochi, India)

    Objective: To perform targeted resequencing of the SNCA locus to identify novel variants in the Indian patients with Parkinsons’s disease (PD). Background: To date, most…
  • 2022 International Congress

    Statin use and incidence of Parkinson’s disease in women from the French E3N cohort study

    TTH. Nguyen, A. Fournier, E. Courtois, F. Artaud, S. Escolano, P. Tubert-Bitter, MC. Boutron-Ruault, I. Degaey, E. Roze, M. Canonico, I. Ahmed, ACM. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine whether incident statin use is associated with lower Parkinson’s disease (PD) incidence while considering the potential for reverse causation. Background: Drug repurposing…
  • 2022 International Congress

    Association between income and hospital length of stay in Parkinson Disease: a nationwide cross-sectional analysis

    P. Gros, D. Di Luca, C. Marras, A. Lang (Toronto, Canada)

    Objective: To investigate the relationship between income and hospital length of stay (LOS) and discharge disposition in a Parkinson Disease (PD) cohort admitted to the…
  • 2022 International Congress

    Time reproduction in Parkinson’s disease: Is there a specific impairment in context of movements?

    M. Ruppert, L. Torfah, V. Hammes, A. Greuel, F. Maier, L. Timmermann, D. Pedrosa Carrasco, C. Eggers (Marburg, Germany)

    Objective: Investigating the reproduction of time intervals in context of a motor imagery task in Parkinson’s disease Background: In Parkinson’s disease (PD), impaired perception of…
  • « Previous Page
  • 1
  • …
  • 231
  • 232
  • 233
  • 234
  • 235
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley